Cervix CA Flashcards

1
Q

What are the usual histologies for Cervix CA?

A

1) Squamous Cell Carcinoma (80%) - High risk
- Large cell Keratinising
- Large cell non-Keratinising
- Small Cell
2) AdenoCarcinoma (15%) - High risk
3) Neuroendocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for Cervix CA?

A

1) Smoking
2) immunocompromised
3) Early age of 1st sexual activity
4) multiple parity
5) Earlier age at first birth
6) Multiple sexual partners
7) Hx of STIs
8) Hx of vulvar/vaginal intraepithelial neoplasms or cancer
9) High risk sexual partner
10) non-white
11) Lower socio-economic status
12) Genetics
13) Sex with uncircumcised male
14) Oral contraceptives usage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tell me more about HPV infection

A

As high as 45% in women 25-29yo in US
Majority clear the virus w/o specific intervention (90%)
In a minority, the virus persistS

With persistent infection, HPV Genes E6 and E7 are incorporated into cervix cells

  • Viral proteins capable of binding to and inactivating tumor suppression proteins are produced. (
  • HPV subtype 15 high risk
  • HPV 16 and HPV 18 most prevalent, and are responsible for >70% of cervical cancer worldwide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 HPV Vaccines that you know of:

A

Gardasil (6,11,16,18)

Cervarix (16,18)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the low risk HPV subtypes

A

6,11

- low grade squamous intra-epithelial lesion (SIL)/condylomata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the high risk subtypes for HPV?

A

16,18, 31, 33, 52

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tell me in brief the FIGO staging for Cervix CA

A

I - Limited to uterus

I - Extends beyond the cervix, but not to the pelvic side wall or to lower 1/3 of vagina

III - Extends to pelvic side wall or to lower 1/3 of the vagina, or causes hydronephrosis

IV - extends beyond true pelvis; and/or invades mucosa of bladder/rectum; or distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tell me about FIGO Stage I of the cervix

A

IA:
- invasive carcinoma Dx only by microscopy
IA1:
Lesions 3 cm or less in depth of stromal invasion, 3m and 4cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tell me about FIGO stage II of cervical CA

A

II: tumor extends beyond cervix, but not to pelvic side wall and not to lower 1/3 of vagina

IIA1: No parametric like invasion, clinically visible lesion 4cm

IIB: extends to parametria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tell me about FIGO stage 4 for cervix

A

IVA: Extends beyond true pelvis, and/or invades mucosa of bladder/rectum

IVB: Distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the GOG score?

A

= relative risk for the depth X tumor size X capillary space involvement

GOG score 120 = Standard field RT+ brachytherapy OR Small field RT+Brachytherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the indications for adjuvant RT?

A

> pT2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the Sedilis Criteria?

A

1) >1/3 stromal invasion
2) LVSI
3) Tumor size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 5 trials that show better survival rates with concurrent ChemoRT for locally advanced Cervical CA?

A

1) GOG 123
2) GOG 120
3) GOG 85
4) SWOG 8797
5) RTOG 9001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is GOG 123?

A

Stehman et al

Aim: Confirm tt concurrent ChemoRT with CDDP a/w improved long-term PFS and OS compared with RT alone in stage IB bulky cervix CA

N=370
Bulky Stage IB cervix Ca, randomized to 2 arms
2 arms:
1) Chemo/RT
2) RT alone 

RESULTS:
4y OS: 85% vs 75% (RT alone)
4y PFS 80% vs 60% (RT alone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is GOG 120

A

Peter Rose JCO 2007 (updated analysis at 8y)

N=500
Locally advanced with pathologically Negative para-aortic LN
S/p external-beam RT according to a strict protocol

3 arms:

1) CDDP (40)X 6 weeks
2) CDDP (50) D1, D29 –> FU 4g/m2 over 96 hours D1, 29 + 2g/m2 Hydroxyurea twice weekly X 6 weeks
3) 3g/m2 Oral hydroxyurea twice weekly for 6 weeks

RESULTS:
CDDP-based chemo during pelvic RT improves long-term PFS and OS
No observed increase in late toxicity with CDDP-based ChemoRT.

17
Q

Tell me about the SWOG 8797

A

Peters et al
N=250
CS IA2, IB, IIA s/p radical hysterectomy and pelvic lymphadenectomy ,+positive LN and/or +margins and/or microscopic involvement of the parametrium

2 arms:

1) RT
2) RT + Chemo

RESULTS:
4y PFS 80% vs 60%(RT)
4y OS 80% vs 70%